BACKGROUND: Higher intake of omega-3 fatty acids (n-3 FAs) is associated with a reduced
risk of Alzheimer's disease (AD) and milder forms of cognitive impairment (eg cognitive …

Incomplete response to monoaminergic antidepressants in major depressive disorder (MDD),
and the phenomenon of neuroprogression, suggests a need for additional …

Background Major depressive disorder (MDD) may be associated with oxidative damage to
lipids, which can potentially affect mood-regulating pathways. This meta-analysis …

Background Zinc is an essential micronutrient with diverse biological roles in cell growth,
apoptosis and metabolism, and in the regulation of endocrine, immune, and neuronal functions …

BACKGROUND: Inflammatory activity plays a role in the development and progression of
coronary artery disease (CAD), and exercise confers survival benefit. We performed a meta-…

Objective: This meta-analysis examined the effects of cholinesterase inhibitor (ChEI)
discontinuation in patients with Alzheimer’s disease (AD). Data Sources: Electronic records up to …

This trial investigated the efficacy of omega-3 polyunsaturated fatty acid (n-3 PUFA) treatment
for improving depressive symptoms and cognitive performance in patients with coronary …

2. Background Endogenous opioids produce analgesia by activating mu, delta, and kappa
opioid receptors. Although activation of mu and delta receptors typically imparts a pleasant or …

The persistence of a depressive episode in coronary artery disease (CAD) patients not only
heightens the risk of acute ischemic events, but it is also associated with accelerated …

Background Antidepressant efficacy of omega-3 polyunsaturated fatty acid (n-3 PUFA)
treatment in coronary artery disease (CAD) patients remains unpredictable. N-3 PUFA can …